| Literature DB >> 32110170 |
Syed Ali Raza Naqvi1, Syed Muhammad Ali Shah2, Laiba Kanwal1, Muhammad Saeed1, Jaweria Nisar2, Zonaira Nisar3, Muhammad Akram2.
Abstract
Multidrug resistance has increased globally in the communities. Bacterial infections associated with health care have weakened the existing antimicrobial therapy and demand the search for alternative therapies. In the present investigation, the medicinal plant Pulicaria gnaphalodes from Quetta, Pakistan, has been screened for antimicrobial potential. In vitro antimicrobial efficacy of P gnaphalodes extracts (methanol and ethanol) was quantitatively evaluated on the basis of zone of inhibition against different bacteria and minimum inhibitory concentration (MIC). In vivo, antihypercholesterolemic activity is determined in different rat groups. The results of the study indicated that the ethanol extract of P gnaphalodes showed maximum zone of inhibition for Bacillus subtilis of 12.1 ± 1.1 mm from all others. The methanol extract showed maximum zone of inhibition for Staphylococcus aureus of 11.9 ± 1.0 mm and rifampicin showed maximum zone of inhibition of 23.1 ± 0.9 mm. The results of ethanol and methanol extract of P gnaphalodes against different bacteria revealed that this plant has greater antimicrobial activity. However, the plant extract shows nonsignificant antihypercholesterolemic activity. The extract of this plant can be utilized as medicine to inhibit several infections caused by some bacterial pathogens found in human body.Entities:
Keywords: Bacillus subtilis; Escherichia coli; Pasteurella multocida; Pulicaria gnaphalodes; Staphylococcus aureus; antihypercholesterolemic; antimicrobial
Year: 2020 PMID: 32110170 PMCID: PMC7000860 DOI: 10.1177/1559325820904858
Source DB: PubMed Journal: Dose Response ISSN: 1559-3258 Impact factor: 2.658
Antibacterial Activity of Pulicaria Gnaphalodes Extracts and Diameter of Inhibition Zone (mm) Including Well Diameter of 6 mm.a
| Bacterial Strains | Ethanol Extract | Methanol Extract | Rifampicin |
|---|---|---|---|
|
| 10.1 ± 0.9 | 10.7 ± 0.8 | 19.7 ± 0.8 |
|
| 10.8 ± 0.6 | 9.7 ± 1.1 | 21.7 ± 1.1 |
|
| 12.1 ± 1.1 | 11.2 ± 0.9 | 23.1 ± 0.9 |
|
| 11.4 ± 0.8 | 11.9 ± 1.0 | 22.3 ± 1.2 |
a Values are the means ± standard deviation of triplicate.
Figure 1.Escherichia coli and Pasteurella multocida killed by extract of Pulicaria gnaphalodes. The ethanol and methanol extracts of P gnaphalodes show the zone of inhibition in Escherichia coli (A) and Pasteurella multocida (B) bacterial culture plate.
Minimum Inhibitory Activity of Pulicaria gnaphalodes.a
| Bacterial Strains | Ethanol Extract | Methanol Extract | Rifampicin |
|---|---|---|---|
|
| 4.1 ± 0.2 | 3.9 ± 0.2 | 0.5 ± 0.0 |
|
| 3.4 ± 0.1 | 3.4 ± 0.1 | 0.4 ± 0.0 |
|
| 3.1 ± 0.2 | 2.9 ± 0.3 | 0.2 ± 0.0 |
|
| 2.8 ± 0.3 | 3.1 ± 0.2 | 0.1 ± 0.0 |
Abbreviations: MIC, minimum inhibitory concentration.
a Values are the means ± standard deviation of triplicate.
Figure 2.Bacillus subtilis and Staphylococcus aureus killed by extract of Pulicaria gnaphalodes. The ethanol and methanol extracts of P gnaphalodes show the zone of inhibition in Bacillus subtilis (A) and Staphylococcus aureus (B) bacterial culture plate.
Lipid Profile (mg/dL) in Different Groups of Experimental Rats at Day 0 and 30.
| TC | HDL | LDL | Triglyceride | |
|---|---|---|---|---|
| Day 0 | ||||
| Group 1 | 196 ± 1 | 59 ± 1.1 | 137 ± 2 | 151 ± 1 |
| Group 2 | 220 ± 2 | 45 ± 1 | 175 ± 1.9 | 156 ± 2 |
| Group 3 | 224 ± 1.1 | 43 ± 2 | 181 ± 1 | 158 ± 1.1 |
| Group 4 | 218 ± 1.9 | 50 ± 1 | 168 ± 1.5 | 160 ± 1.9 |
| Group 5 | 214 ± 1.6 | 49 ± 1.9 | 165 ± 1.1 | 154 ± 1 |
| Day 30 | ||||
| Group 1 | 200 ± 0.7 | 61 ± 0.2 | 139 ± 0.0 | 153 ± 0.0 |
| Group 2 | 239 ± 0.2 | 40 ± 0.7 | 199 ± 0.8 | 159 ± 0.2 |
| Group 3 | 211 ± 0.7 | 55 ± 0.0 | 156 ± 0.7 | 150 ± 0.8 |
| Group 4 | 229 ± 0.0 | 45 ± 0.8 | 184 ± 0.8 | 166 ± 0.0 |
| Group 5 | 223 ± 0.0 | 44 ± 0.2 | 179 ± 0.2 | 160 ± 0.7 |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol.
Liver Profile (U/L) in Different Groups of Experimental Rats at Day 0 and 30.
| Day 0 | Day 30 | Day 0 | Day 30 | |
|---|---|---|---|---|
| ALT | ALT | ALP | ALP | |
| Group 1 | 39 ± 1.0 | 50.6 ± 0.8 | 246 ± 3.01 | 246.1 ± 3.01 |
| Group 2 | 41 ± 2.0 | 58.9 ± 3.0 | 246 ± 3.01 | 302.9 ± 5.02 |
| Group 3 | 38 ± 1.5 | 45.3 ± 2.9 | 245 ± 3.00 | 347.3 ± 5.55 |
| Group 4 | 42 ± 2.5 | 61.8 ± 3.36 | 245 ± 3.00 | 373.6 ± 6.63 |
| Group 5 | 43 ± 2.6 | 55.0 ± 4.28 | 250 ± 3.05 | 393.1 ± 6.94 |
Abbreviations: ALT, Alanine amino transferase; ALP, alkaline phosphate.
Total Bilirubin, Direct Bilirubin, and Indirect Bilirubin (mg/dL) in Different Groups of Experimental Rats.
| Day 0 | Day30 | Day 0 | Day 30 | Day 0 | Day 30 | |
|---|---|---|---|---|---|---|
| Total | Total | Direct | Direct | Indirect | Indirect | |
| Group 1 | 0.5 ± 0.0 | 0.53 ± 0.1 | 0.23 ± 0.0 | 1.4 ± 0.1 | 0.75 ± 0.0 | 1.8 ± 0.3 |
| Group 2 | 0.4 ± 0.0 | 0.42 ± 0.1 | 0.22 ± 0.0 | 1.2 ± 0.1 | 0.73 ± 0.0 | 1.7 ± 0.2 |
| Group 3 | 0.5 ± 0.0 | 0.53 ± 0.2 | 0.25 ± 0.0 | 1.8 ± 0.3 | 0.68 ± 0.0 | 1.4 ± 0.1 |
| Group 4 | 0.4 ± 0.0 | 0.50 ± 0.0 | 0.22 ± 0.0 | 1.4 ± 0.1 | 0.70 ± 0.0 | 1.6 ± 0.1 |
| Group 5 | 0.5 ± 0.0 | 0.55 ± 0.2 | 0.25 ± 0.0 | 1.8 ± 0.3 | 0.69 ± 0.0 | 1.5 ± 0.1 |